![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Demand for Ivermectin as COVID-19 Treatment Rises Despite Lack of Efficacy
Demand for Ivermectin as COVID-19 Treatment Rises Despite Lack of Efficacy
![Ivermectin - Drug](https://www.fdanews.com/ext/resources/test/Drug-Images4/Ivermectin-drug.gif?t=1630354965&width=430)
Prescriptions for ivermectin, an anti-parasitic used to de-worm animals, have been increasing rapidly in recent weeks despite a lack of evidence of the drug’s clinical effectiveness as a COVID-19 treatment.
The Centers for Disease Control and Prevention (CDC) noted a 24-fold increase in prescriptions from pre-pandemic levels, as well as cases of people ingesting ivermectin-containing products purchased without a prescription, including topical formulations and veterinary products.
Overdoses of ivermectin are linked with low blood pressure, confusion, hallucinations, seizures, coma and even death.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct